ETF

ETF Battles: ARKG Vs GNOM

Which biotech/genomics ETF is the better play?

etf
ETF Battles
|
Jun 08, 2021
Reviewed by: ETF Battles
,
Edited by: ETF Battles
View Bio Follow Author

 

ETF.com's Cinthia Murphy goes four rounds with ETF PM's David Kreinces to decide which is the better biotech/genomics ETF, the ARK Genomic Revolution ETF (ARKG) or the Global X Genomics & Biotechnology ETF (GNOM).

 

 

ETF Battles
View Bio Follow Author

Related Stories

Vanguard
Daily ETF Watch
Vanguard to Launch 2 Active Bond ETFs
Mark Nacinovich | Dec 07, 2023
invest_search.jpeg (318.13 KB)
ETF Basics
10 Best-Performing ETFs of the Last 10 Years
Kent Thune | Dec 07, 2023
China
Features
China ETFs to Consider After Moody's Warning
Rob Isbitts | Dec 07, 2023
Global
News
JPMorgan Launches Global Equity Version of JEPI
Theo Andrew | Dec 06, 2023

Related Topics

Innovative
Biotech
Theme Investing
Active Management
Alpha-Seeking
ARK
Broad-based
Equity
Global
Global X
Healthcare
Mirae Asset Global Investments Co., Ltd.
No Underlying Index
Sectors
Size and Style
Total Market
Vanilla

More From ETF Battles

View All
versus_v2b_bv.jpg (39.41 KB)
News
ETF Battles: QQQ Vs SCHG Vs VOOG
ETF Battles | Feb 24, 2023
versus_v2a_bv.jpg (43.46 KB)
News
ETF Battles: DBA Vs DBC
ETF Battles | Feb 24, 2023
versus_v2a_bv.jpg (43.46 KB)
News
ETF Battles: EMQQ Vs KWEB
ETF Battles | Feb 24, 2023
versus_v2b_bv.jpg (39.41 KB)
News
ETF Battles: IBB Vs XBI
ETF Battles | Feb 24, 2023

Related Media

Fidelity Investments
Features
Fidelity: These Are the 3 Biggest Benefits of Active ETFs
Talk ETFs | Nov 29, 2023
Stock Market Index
Podcasts
Most Passive Indexes Are ‘Arbitrary’
Exchange Traded Fridays | Oct 27, 2023
Build a Portfolio
Features
Active ETFs Can Complement Passive ETFs
Talk ETFs | Oct 27, 2023
Active Management - Investing
Features
Why So Much Money Is Flowing Into Active ETFs
Talk ETFs | Oct 25, 2023